Abstract: Composite particles comprising baculovirus particles in a coating of wax that is degradable in the gut of a larva of an arthropod species, optionally in conjunction with an insecticide, methods of manufacture, uses thereof, and methods of controlling arthropod infestations.

Abstract: The subject matter described in this specification relates generally to a tool for installing a flexible metal conduit screw-in connector onto a flexible metal conduit and a method for installing the flexible metal conduit connector tool. The flexible metal conduit screw-in connector tool includes a handle, a centering rod, and two studs. The flexible metal conduit connector tool is to engage a flexible metal conduit screw-in connector.

Abstract: The subject matter described in this specification relates generally to a tool for installing a flexible metal conduit screw-in connector onto a flexible metal conduit and a method for installing the flexible metal conduit connector tool. The flexible metal conduit screw-in connector tool includes a handle, a centering rod, and two studs. The flexible metal conduit connector tool is to engage a flexible metal conduit screw-in connector.

Abstract: A delivery method for bacteria, viruses, fungi and dsRNA in which the bacteria, virus, fungus or dsRNA is protected from degradation by UV light by encapsulation in a particle of wax also containing a UV blocker. The formulation may also include other chemistry, such as insecticides. The particles are edible by insects and their larva and result in ingestion of the bacteria, virus, fungi and/or dsRNA by the insect or larva, resulting in control thereof.

Abstract: Composite particles comprising baculovirus particles in a coating of wax that is degradable in the gut of a larva of an arthropod species, optionally in conjunction with an insecticide, methods of manufacture, uses thereof, and methods of controlling arthropod infestations.

Abstract: Composite particles comprising baculovirus particles in a coating of wax that is degradable in the gut of a larva of an arthropod species, optionally in conjunction with an insecticide, methods of manufacture, uses thereof, and methods of controlling arthropod infestations.

Abstract: Composite particles comprising baculovirus particles in a coating of wax that is degradable in the gut of a larva of an arthropod species, optionally in conjunction with an insecticide, methods of manufacture, uses thereof, and methods of controlling arthropod infestations.

Abstract: In one embodiment, an apparatus includes a controller to control a voltage regulator. The controller may have a first comparator circuit to compare a first reference voltage to a feedback voltage. In turn, the first comparator circuit may include: a first comparator having a first input terminal to receive the feedback voltage and a second input terminal to receive the reference voltage and an output node to output an error signal based on the comparison; and a first pre-charge circuit coupled between the first input terminal and the output node configured to pre-charge a first portion of a compensation network to a pre-charge level. The first controller may further include a second comparator circuit coupled to the first comparator circuit compare the error signal to a ramp signal and to generate a first control output to control a power train of the voltage regulator in a first mode of operation.

Abstract: An atlas application enables an electronic display device to receive touch input from a user on a screen of the display device to access an atlas database to obtain graphic map information representative of a portion of the surface of the earth and to display the obtained graphic map information on the screen of the display as a graphic map showing a plurality of points of interest on the portion of the surface of the earth. The user is able to manipulate the graphic map by touch to locate and select a particular point of interest for detailed examination. The atlas data may contain at least one of descriptive textual information and graphic map information representative of particular points of interest selected by the user. A position of the device may be selected or determined to assist in presenting various points of interest for perusal.

Abstract: In some embodiments, a wastewater treatment system may reduce contaminants in water. A system may include one or more bioreactors which include a substrate that supports a biofilm. The bacteria used to form the biofilm may be selected to maximize the reduction of contaminants in water. Various components of the wastewater treatment system may be optimized to improve the efficiency and energy consumption of the wastewater system.

Abstract: In one embodiment, an apparatus includes a controller to control a voltage regulator. The controller may have a first comparator circuit to compare a first reference voltage to a feedback voltage. In turn, the first comparator circuit may include: a first comparator having a first input terminal to receive the feedback voltage and a second input terminal to receive the reference voltage and an output node to output an error signal based on the comparison; and a first pre-charge circuit coupled between the first input terminal and the output node configured to pre-charge a first portion of a compensation network to a pre-charge level. The first controller may further include a second comparator circuit coupled to the first comparator circuit compare the error signal to a ramp signal and to generate a first control output to control a power train of the voltage regulator in a first mode of operation.

Abstract: An atlas application enables an electronic display device to receive touch input from a user on a screen of the display device to access an atlas database to obtain graphic map information representative of a portion of the surface of the earth and to display the obtained graphic map information on the screen of the display as a graphic map showing a plurality of points of interest on the portion of the surface of the earth. The user is able to manipulate the graphic map by touch to locate and select a particular point of interest for detailed examination. The atlas data may contain at least one of descriptive textual information and graphic map information representative of particular points of interest selected by the user. A position of the device may be selected or determined to assist in presenting various points of interest for perusal.

Abstract: The invention is directed to compounds of Formula I: wherein Z, X, J, R2 and W are set forth in the specification, as well as solvates, hydrates, tautomers and pharmaceutically acceptable salts thereof, that inhibit protein tyrosine kinases, especially c-fms kinase. Methods of treating autoimmune diseases; and diseases with an inflammatory component; treating metastasis from ovarian cancer, uterine cancer, breast cancer, colon cancer, stomach cancer, hairy cell leukemia and non-small lung carcinoma; and treating pain, including skeletal pain caused by tumor metastasis or osteoarthritis, or visceral, inflammatory, and neurogenic pain; as well as osteoporosis, Paget's disease, and other diseases in which bone resorption mediates morbidity including arthritis, prosthesis failure, osteolytic sarcoma, myeloma, and tumor metastasis to bone with the compounds of Formula I, are also provided.

Abstract: The invention is directed to compounds of Formula I: wherein Z, X, J, R2 and W are set forth in the specification, as well as solvates, hydrates, tautomers and pharmaceutically acceptable salts thereof, that inhibit protein tyrosine kinases, especially c-fms kinase. Methods of treating autoimmune diseases; and diseases with an inflammatory component; treating metastasis from ovarian cancer, uterine cancer, breast cancer, prostate cancer, lung cancer, colon cancer, stomach cancer, hairy cell leukemia; and treating pain, including skeletal pain caused by tumor metastasis or osteoarthritis, or visceral, inflammatory, and neurogenic pain; as well as osteoporosis, Paget's disease, and other diseases in which bone resorption mediates morbidity including rheumatoid arthritis, and other forms of inflammatory arthritis, osteoarthritis, prosthesis failure, osteolytic sarcoma, myeloma, and tumor metastasis to bone with the compounds of Formula I, are also provided.

Abstract: The invention is directed to compounds of Formula I: wherein Z, X, J, R2 and W are set forth in the specification, as well as solvates, hydrates, tautomers and pharmaceutically acceptable salts thereof, that inhibit protein tyrosine kinases, especially c-fms kinase. Methods of treating autoimmune diseases; and diseases with an inflammatory component; treating metastasis from ovarian cancer, uterine cancer, breast cancer, prostate cancer, lung cancer, colon cancer, stomach cancer, hairy cell leukemia; and treating pain, including skeletal pain caused by tumor metastasis or osteoarthritis, or visceral, inflammatory, and neurogenic pain; as well as osteoporosis, Paget's disease, and other diseases in which bone resorption mediates morbidity including rheumatoid arthritis, and other forms of inflammatory arthritis, osteoarthritis, prosthesis failure, osteolytic sarcoma, myeloma, and tumor metastasis to bone with the compounds of Formula I, are also provided.

Abstract: The invention is directed to compounds of Formula I: wherein Z, X, J, R2 and W are set forth in the specification, as well as solvates, hydrates, tautomers and pharmaceutically acceptable salts thereof, that inhibit protein tyrosine kinases, especially c-fms kinase. Methods of treating autoimmune diseases; and diseases with an inflammatory component; treating metastasis from ovarian cancer, uterine cancer, breast cancer, prostate cancer, lung cancer, colon cancer, stomach cancer, hairy cell leukemia; and treating pain, including skeletal pain caused by tumor metastasis or osteoarthritis, or visceral, inflammatory, and neurogenic pain; as well as osteoporosis, Paget's disease, and other diseases in which bone resorption mediates morbidity including rheumatoid arthritis, and other forms of inflammatory arthritis, osteoarthritis, prosthesis failure, osteolytic sarcoma, myeloma, and tumor metastasis to bone with the compounds of Formula I, are also provided.

Abstract: A downhole activation system within a tubular. The system includes an axially movable member; a first magnetic field source having a first field with a first axial orientation movable with the member. A second magnetic field source having a second field with an axial orientation different from the first orientation and separated from the first magnetic field source. The second field being magnetically repulsed by the first field; and, a biasing device urging the second magnetic field source towards the first magnetic field source; wherein movement of the first magnet via the member towards the second magnet moves the second magnet in a direction against the biasing device. A method of activating an activatable member in a downhole tubular.

Abstract: A downhole activation system within a tubular. The system includes an axially movable mover. A first magnet attached to the mover. The first magnet axially movable with the mover. A second magnet separated from the first magnet. The second magnet magnetically repulsed by the first magnet. A biasing device urging the second magnet towards the first magnet; wherein movement of the first magnet via the mover towards the second magnet moves the second magnet in a direction against the biasing device. Also included is a method of activating an activatable member in a downhole tubular.

Abstract: The invention is directed to compounds of Formula I: wherein Z, X, J, R2 and W are set forth in the specification, as well as solvates, hydrates, tautomers and pharmaceutically acceptable salts thereof, that inhibit protein tyrosine kinases, especially c-fms kinase. Methods of treating autoimmune diseases; and diseases with an inflammatory component; treating metastasis from ovarian cancer, uterine cancer, breast cancer, prostate cancer, lung cancer, colon cancer, stomach cancer, hairy cell leukemia; and treating pain, including skeletal pain caused by tumor metastasis or osteoarthritis, or visceral, inflammatory, and neurogenic pain; as well as osteoporosis, Paget's disease, and other diseases in which bone resorption mediates morbidity including rheumatoid arthritis, and other forms of inflammatory arthritis, osteoarthritis, prosthesis failure, osteolytic sarcoma, myeloma, and tumor metastasis to bone with the compounds of Formula I, are also provided.

Abstract: The invention is directed to compounds of Formula I: wherein Z, X, J, R2 and W are set forth in the specification, as well as solvates, hydrates, tautomers and pharmaceutically acceptable salts thereof, that inhibit protein tyrosine kinases, especially c-fms kinase. Methods of treating autoimmune diseases; and diseases with an inflammatory component; treating metastasis from ovarian cancer, uterine cancer, breast cancer, colon cancer, stomach cancer, hairy cell leukemia and non-small lung carcinoma; and treating pain, including skeletal pain caused by tumor metastasis or osteoarthritis, or visceral, inflammatory, and neurogenic pain; as well as osteoporosis, Paget's disease, and other diseases in which bone resorption mediates morbidity including arthritis, prosthesis failure, osteolytic sarcoma, myeloma, and tumor metastasis to bone with the compounds of Formula I, are also provided.